New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology
The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Although debated for many years whether haemodynamic or structural changes are more important in the development of diabetic nephropathy, it is now clear that these processes are interwoven and present two sides of one coin. On a molecular level, hyperglycaemia and proteins altered by high blood glucose such as Amadori products and advanced glycation end‐products (AGEs) are key players in the development of diabetic nephropathy. Recent evidence suggests that an increase in reactive oxygen species (ROS) formation induced by high glucose‐mediated activation of the mitochondrial electron‐transport chain is an early event in the development of diabetic complications. A variety of growth factors and cytokines are then induced through complex signal transduction pathways involving protein kinase C, mitogen‐activated protein kinases, and the transcription factor NF‐κB. High glucose, AGEs, and ROS act in concert to induce growth factors and cytokines. Particularly, TGF‐β is important in the development of renal hypertrophy and accumulation of extracellular matrix components. Activation of the renin‐angiotensin system by high glucose, mechanical stress, and proteinuria with an increase in local formation of angiotensin II (ANG II) causes many of the pathophysiological changes associated with diabetic nephropathy. In fact, it has been shown that angiotensin II is involved in almost every pathophysiological process implicated in the development of diabetic nephropathy (haemodynamic changes, hypertrophy, extracellular matrix accumulation, growth factor/cytokine induction, ROS formation, podocyte damage, proteinuria, interstitial inflammation). Consequently, blocking these deleterious effects of ANG II is an essential part of every therapeutic regiment to prevent and treat diabetic nephropathy. Recent evidence suggests that regression of diabetic nephropathy could be achieved under certain circumstances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Structural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
Zatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
Podocyte loss and progressive glomerular injury in type II diabetes.
Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119163 · Cited by 1,088
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,072
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
Ritz, E., Rychlík, I., Locatelli, F., & Halimi, S. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70035-1 · Cited by 806
Regression of Microalbuminuria in Type 1 Diabetes
Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021835 · Cited by 801
Kanellis, J., Watanabe, S., Li, J. H., Kang, D. H., Li, P., Nakagawa, T., Wamsley, A., Sheikh-Hamad, D., Lan, H. Y., Feng, L., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000072820.07472.3b · Cited by 786
Intercapillary Lesions in the Glomeruli of the Kidney.
Kimmelstiel, P., & Wilson, C. (1936) · PubMed · Cited by 661
Extracellular Matrix Metabolism in Diabetic Nephropathy
Mason, R. M., & Wahab, N. A. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065640.77499.d7 · Cited by 655
Ziyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Self-citationNephropathy in Patients with Type 2 Diabetes
Remuzzi, G., Schieppati, A., & Ruggenenti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011773 · Cited by 587
The Pattern Recognition Receptor (RAGE) Is a Counterreceptor for Leukocyte Integrins
Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T., Nagashima, M., Morser, J., Arnold, B., Preissner, K. T., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030800 · Cited by 582
Progression, remission, regression of chronic renal diseases
Ruggenenti, P., Schieppati, A., & Remuzzi, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04728-0 · Cited by 554
Yan, S. F., Ramasamy, R., Naka, Y., & Schmidt, A. M. (2003) · Circulation Research · doi:10.1161/01.res.0000103862.26506.3d · Cited by 513
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology
Schrijvers, B. F., Flyvbjerg, A., & De Vriese, A. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00621.x · Cited by 504
Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice
Yamamoto, Y., Kato, I., Doi, T., Yonekura, H., Ohashi, S., Takeuchi, M., Watanabe, T., Yamagishi, S.-I., Sakurai, S., Takasawa, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11771 · Cited by 475
Molecular mechanisms of diabetic renal hypertrophy
Wolf, G., & Ziyadeh, F. N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00590.x · Cited by 472
Self-citationEffectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
Sato, A., Hayashi, K., Naruse, M., & Saruta, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000044937.95080.e9 · Cited by 466
Mediators of Diabetic Renal Disease: The Case for TGF-β as the Major Mediator
Ziyadeh, F. N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000093460.24823.5b · Cited by 463
DE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v125993 · Cited by 442
Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., & Kurokawa, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119853 · Cited by 433
Kolm-Litty, V, Sauer, U., Nerlich, A., Lehmann, R., & Schleicher, E. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119875 · Cited by 430
Gouva, C., Nikolopoulos, P., Ioannidis, J. P. A., & Siamopoulos, K. C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00797.x · Cited by 410
Glomerular cell number in normal subjects and in type 1 diabetic patients
Steffes, M. W., Schmidt, D., Mccrery, R., & Basgen, J. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00725.x · Cited by 408
NF- B activation and overexpression of regulated genes in human diabetic nephropathy
Mezzano, S., Aros, C., Droguett, A., Burgos, M. E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., & Egido, J. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh207 · Cited by 381
Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes
Coimbra, T. M., Janssen, U., Gröne, H. J., Ostendorf, T., Kunter, U., Schmidt, H., Brabant, G., & Floege, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00836.x · Cited by 377
High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β
Wolf, G., Sharma, K., Chen, Y., Ericksen, M., & Ziyadeh, F. N. (1992) · Kidney International · doi:10.1038/ki.1992.330 · Cited by 356
Self-citationAdiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice
Takahashi, K., Mizuarai, S., Araki, H., Mashiko, S., Ishihara, A., Kanatani, A., Itadani, H., & Kotani, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309895200 · Cited by 327
Imperatore, G., Hanson, R. L., Pettitt, D. J., Kobes, S., Bennett, P. H., & Knowler, W. C. (1998) · Diabetes · doi:10.2337/diabetes.47.5.821 · Cited by 326
Podocyte Number in Normotensive Type 1 Diabetic Patients With Albuminuria
White, K. E., Bilous, R. W., Marshall, S. M., El Nahas, M., Remuzzi, G., Piras, G., De Cosmo, S., Viberti, G., & (ESPRIT), O. B. O. T. E. S. F. T. P. O. R. D. I. T. 1. D. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3083 · Cited by 315
Durvasula, R. V., Petermann, A. T., Hiromura, K., Blonski, M., Pippin, J., Mundel, P., Pichler, R., Griffin, S., Couser, W. G., & Shankland, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00362.x · Cited by 313
Fine, L. G., Bandyopadhay, D., & Norman, J. T. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07512.x · Cited by 312
Is Podocyte Injury Relevant in Diabetic Nephropathy?
Dalla Vestra, M., Masiero, A., Roiter, A. M., Saller, A., Crepaldi, G., & Fioretto, P. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1031 · Cited by 301
Miyata, T., van Ypersele de Strihou, C., Ueda, Y., Ichimori, K., Inagi, R., Onogi, H., Ishikawa, N., Nangaku, M., & Kurokawa, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032418.67267.f2 · Cited by 290
Aldosterone in the development and progression of renal injury
Hollenberg, N. K. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00701.x · Cited by 273
Microvascular basement membranes in diabetes mellitus
Tsilibary, E. C. (2003) · The Journal of Pathology · doi:10.1002/path.1439 · Cited by 267
Cooper, M. E., Boner, G., Cao, Z., Kawachi, H., Bonnet, F., & Allen, T. J. (2001) · Diabetologia · doi:10.1007/s001250100546 · Cited by 249
Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy
Mohanram, A., Zhang, Z., Shahinfar, S., Keane, W. F., Brenner, B. M., & Toto, R. D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00863.x · Cited by 245
Kidney function in early diabetes: the tubular hypothesis of glomerular filtration
Thomson, S. C., Vallon, V., & Blantz, R. C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00208.2003 · Cited by 244
The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanisms
Wolf, G., & Ziyadeh, F. N. (1997) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(97)90023-8 · Cited by 236
Self-citationEsteban, V., Lorenzo, O., Rupe[Combining Acute Accent]rez, M. A. A., Suzuki, Y., Mezzano, S., Blanco, J., Kretzler, M., Sugaya, T., Egido, J. A. A., & Ruiz-Ortega, M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130564.75008.f5 · Cited by 234
Huang, X. R., Chen, W. Y., Truong, L. D., & Lan, H. Y. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000071512.93927.4e · Cited by 228
Wolf, G., Wenzel, U., Burns, K. D., Harris, R. C., Stahl, R. A. K., & Thaiss, F. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00365.x · Cited by 226
Self-citationDiabetic nephropathy: Prevention and treatment
Parving, H.-H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00020.x · Cited by 226
Vidotti, D. B., Casarini, D. E., Cristovam, P. C., Leite, C. A., Schor, N., & Boim, M. A. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00371.2003 · Cited by 224
Aldosterone Potentiates Angiotensin II–Induced Signaling in Vascular Smooth Muscle Cells
Mazak, I., Fiebeler, A., Muller, D. N., Park, J.-K., Shagdarsuren, E., Lindschau, C., Dechend, R., Viedt, C., Pilz, B., Haller, H., et al. (2004) · Circulation · doi:10.1161/01.cir.0000131860.80444.ab · Cited by 218
Li, J. H., Wang, W., Huang, X. R., Oldfield, M., Schmidt, A. M., Cooper, M. E., & Lan, H. Y. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63225-7 · Cited by 217
The Renin-Angiotensin System and Progression of Renal Disease: From Hemodynamics to Cell Biology
Wolf, G., Butzmann, U., & Wenzel, U. O. (2002) · Nephron Physiology · doi:10.1159/000066656 · Cited by 211
Self-citationFlyvbjerg, A. (2000) · Diabetologia · doi:10.1007/s001250051515 · Cited by 203
Hoffmann, S., Podlich, D., Ha[Combining Diaeresis]hnel, B., Kriz, W., & Gretz, N. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000127988.42710.a7 · Cited by 201
Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes
Utimura, R., Fujihara, C. K., Mattar, A. L., Malheiros, D. M. A. C., de Lourdes Noronha, I., & Zatz, R. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00736.x · Cited by 196
Hsieh, T.-J. (2002) · Endocrinology · doi:10.1210/en.143.8.2975 · Cited by 190
Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy
Mezzano, S., Droguett, A., Burgos, M. E., Ardiles, L. G., Flores, C. A., Aros, C. A., Caorsi, I., Vío, C. P., Ruiz-Ortega, M., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.64.s86.12.x · Cited by 189
Bahlmann, F. H., Song, R., Boehm, S. M., Mengel, M., von Wasielewski, R., Lindschau, C., Kirsch, T., de Groot, K., Laudeley, R., Niemczyk, E., et al. (2004) · Circulation · doi:10.1161/01.cir.0000139335.04152.f3 · Cited by 187
Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats
Fujisawa, G., Okada, K., Muto, S., Fujita, N., Itabashi, N., Kusano, E., & Ishibashi, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00913.x · Cited by 179
BMP7 antagonizes TGF-β-dependent fibrogenesis in mesangial cells
Wang, S., & Hirschberg, R. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00382.2002 · Cited by 177
A genome scan for diabetic nephropathy in African Americans
Bowden, D. W., Colicigno, C. J., Langefeld, C. D., Sale, M. M., Williams, A., Anderson, P. J., Rich, S. S., & Freedman, B. I. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00915.x · Cited by 174
Abbate, M., Zoja, C., Morigi, M., Rottoli, D., Angioletti, S., Tomasoni, S., Zanchi, C., Longaretti, L., Donadelli, R., & Remuzzi, G. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64495-1 · Cited by 170
Hoffman, B. B., Sharma, K., Zhu, Y., & Ziyadeh, F. N. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00119.x · Cited by 168
Advanced glycation end products and the progressive course of renal disease
Heidland, A., Sebekova, K., & Schinzel, R. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27414 · Cited by 168
Weston, B. S., Wahab, N. A., & Mason, R. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000051600.53134.b9 · Cited by 161
Structural involvement in type 1 and type 2 diabetic nephropathy.
Vestra, M. D., Saller, A., Bortoloso, E., Mauer, M. S., & Fioretto, P. (2000) · PubMed · Cited by 160
Lee, F. T. H., Cao, Z., Long, D. M., Panagiotopoulos, S., Jerums, G., Cooper, M. E., & Forbes, J. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135055.61833.a8 · Cited by 151
Mechanism of Increased Angiotensin II Levels in Glomerular Mesangial Cells Cultured in High Glucose
Singh, R., Singh, A. K., Alavi, N., & Leehey, D. J. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000060804.40201.6e · Cited by 149
Gilbert, R. E., Mifsud, S., Hulthén, U. L., Wilkinson‐Berka, J. L., Bertram, J. F., Allen, T. J., Cooper, M. E., & Kelly, D. J. (2001) · Diabetologia · doi:10.1007/s001250100561 · Cited by 143
Menne, J., Park, J.-K., Boehne, M., Elger, M., Lindschau, C., Kirsch, T., Meier, M., Gueler, F., Fiebeler, A., Bahlmann, F. H., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2101 · Cited by 139
Kelly, D. J., Aaltonen, P., Cox, A. J., Rumble, J. R., Langham, R., Panagiotopoulos, S., Jerums, G., Holthöfer, H., & Gilbert, R. E. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.7.1327 · Cited by 139
Koch, A., Kuhlmann, A., M�nter, K., Ritz, E., Amann, K., Gross, M.-L., Elshakmak, A., & Sz�b�, A. (2003) · Diabetologia · doi:10.1007/s00125-003-1106-8 · Cited by 128
Overview of Glucose Signaling in Mesangial Cells in Diabetic Nephropathy
Haneda, M., Koya, D., Isono, M., & Kikkawa, R. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000064500.89551.76 · Cited by 126
Role of Growth Factors in the Development of Diabetic Complications
Chiarelli, F., Santilli, F., & Mohn, A. (2000) · Hormone Research in Paediatrics · doi:10.1159/000023515 · Cited by 120
Diabetic Nephropathy in Type 2 Diabetes Prevention and Patient Management
Wolf, G., & Ritz, E. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065639.19190.cf · Cited by 119
Self-citationWolf, G., Schroeder, R., Zahner, G., Stahl, R. A. K., & Shankland, S. J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64056-4 · Cited by 112
Self-citationPoczatek, M. H., Hugo, C., Darley-Usmar, V. M., & Murphy-Ullrich, J. E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64649-4 · Cited by 111
The inflammatory component in progressive renal disease—are interventions possible?
Noronha, I. L., Fujihara, C. K., & Zatz, R. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.3.363 · Cited by 105
Superoxide generation by lipoxygenase in the presence of NADH and NADPH
Roy, P., Roy, S. K., Mitra, A., & Kulkarni, A. P. (1994) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)90041-8 · Cited by 103
Wolf, G., Schroeder, R., Ziyadeh, F. N., Thaiss, F., Zahner, G., & Stahl, R. A. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.3.f348 · Cited by 102
Self-citationGaßler, N., Elger, M., Kränzlin, B., Kriz, W., Gretz, N., Hähnel, B., Hosser, H., & Hartmann, I. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00777.x · Cited by 95
Angiotensin II depolarizes podocytes in the intact glomerulus of the Rat.
Gloy, J., Henger, A., Fischer, K.-G., Nitschke, R., Mundel, P. H., Bleich, M., Schollmeyer, P. J., Greger, R. F., & Pavenstädt, H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119467 · Cited by 90
Structural and Functional Changes of Laminin and Type IV Collagen After Nonenzymatic Glycation
CHARONIS, A. S., & Tsilibary, E. C. (1992) · Diabetes · doi:10.2337/diab.41.2.s49 · Cited by 86
Diabetic nephropathy: Etiologic and therapeutic considerations
DeFronzo, R. A. (1995) · Diabetes reviews · Cited by 83
Weigert, C., Brodbeck, K., Sawadogo, M., Häring, H. U., & Schleicher, E. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313524200 · Cited by 80
Blockade of maitotoxin-induced endothelial cell lysis by glycine and l -alanine
Estación, M., Weinberg, J. S., Sinkins, W. G., & Schilling, W. P. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00258.2002 · Cited by 80
Kang, S., Natarajan, R. D., SHAHED, A. R., Nast, C. C., LaPage, J. A., Mundel, P. H., Kashtan, C. E., & Adler, S. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000099702.16315.de · Cited by 71
After all those fat years: renal consequences of obesity
Wolf, G. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg427 · Cited by 68
Self-citationWolf, G., Reinking, R. R., Zahner, G., Stahl, R. A. K., & Shankland, S. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1163-z · Cited by 62
Self-citationGenomic Strategies for Diabetic Nephropathy
Suszták, K., Sharma, K., Schiffer, M., McCue, P. A., Ciccone, E., & Diaeresisttinger, E. P. B. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000078035.81397.8a · Cited by 60
Fractalkine and Its Receptor, CX3CR1, Upregulation in Streptozotocin-Induced Diabetic Kidneys
Kikuchi, Y., Ikee, R., Hemmi, N., Hyodo, N., Saigusa, T., Namikoshi, T., Yamada, M., Suzuki, S., & Miura, S. (2004) · Nephron Experimental Nephrology · doi:10.1159/000077594 · Cited by 56
Wolf, G., Schroeder, R., & Stahl, R. A. K. (2004) · American Journal of Nephrology · doi:10.1159/000080086 · Cited by 54
Self-citationWolf, G., Wenzel, U. O., Ziyadeh, F. N., & Stahl, R. A. K. (1999) · Diabetologia · doi:10.1007/s001250051314 · Cited by 54
Self-citationMorrison, J., Knoll, K., Hessner, M. J., & Liang, M. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00031.2004 · Cited by 53
Sharma, K., Deelman, L., Madesh, M., Kurz, B., Ciccone, E., Siva, S., Hu, T., Zhu, Y., Wang, L., Henning, R. H., et al. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00145.2003 · Cited by 51
Zheng, F., Cornacchia, F., Schulman, I. H., Banerjee, A., Cheng, Q.-L., Potier, M., Plati, A. R., Berho, M. E., Elliot, S. J., Li, J., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2420 · Cited by 50
Saito, A., Nagai, R., Tanuma, A., Hama, H., Cho, K., Takeda, T., Yoshida, Y., Toda, T., Shimizu, F., Horiuchi, S., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000062962.51879.f8 · Cited by 48
Glucose-Modified Proteins Modulate Essential Functions and Apoptosis of Polymorphonuclear Leukocytes
Cohen, G., Rudnicki, M., Roth‐Walter, F., Niwa, T., & Diaeresisrl, W. H. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261264 · Cited by 45
Growth factors and the development of diabetic nephropathy
Wolf, G. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0012-2 · Cited by 41
Self-citationOnozaki, A., Midorikawa, S., Sanada, H., Hayashi, Y., Baba, T., Katoh, T., & Watanabe, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.175 · Cited by 39
Remission and Regression of Diabetic Nephropathy
Makino, H., Nakamura, Y., & Wada, J. (2003) · Hypertension Research · doi:10.1291/hypres.26.515 · Cited by 33
Datta, K., Li, J., Karumanchi, S. A., Wang, E., Rondeau, É., & Mukhopadhyay, D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00910.x · Cited by 30
Novel Aspects of Transforming Growth Factor-Beta in Diabetic Kidney Disease
Tsuchida, K., Cronin, B., & Sharma, K. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000064486 · Cited by 16
Couser, W. G. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000090474.05085.05 · Cited by 12
Cited by
Advanced Glycation End Products and Diabetic Complications
Singh, V. P., Bali, A., Singh, N., & Jaggi, A. S. (2014) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2014.18.1.1 · Cited by 1,518
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 641
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S., & Danesh, F. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0705-mr-134 · Cited by 596
Metadata
- Authors
- Wolf, G.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 34
- Issue
- 12
- Pages
- 785-796
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W2040722201
- Cited by
- 360
- References
- 105
- FWCI
- 11.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.